ASA Biopharmaceutical Report

ASA Biopharmaceutical Report

Share this post

ASA Biopharmaceutical Report
ASA Biopharmaceutical Report
2024 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop Session on “Bayesian shrinkage estimation for subgroups: Is it ready for prime time?”

2024 ASA Biopharmaceutical Section…

ASA Biopharmaceutical Report
Dec 19, 2024

Share this post

ASA Biopharmaceutical Report
ASA Biopharmaceutical Report
2024 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop Session on “Bayesian shrinkage estimation for subgroups: Is it ready for prime time?”

Björn Bornkamp (Novartis), David Ohlssen(Novartis), Mark Rothmann (FDA), Chenguang Wang and Dong Xi (Gilead)

Read →
Comments
User's avatar
© 2025 ASA Biopharmaceutical Report
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share